Darden Thaddeus

Director Darden Thaddeus purchases 3,000 shares of GRNT at $5.63; stock up 16.6% in 30 days but down 3.6% annual revenue growth.

Director Darden Thaddeus acquired 3,000 shares at $5.63, bringing his holdings to 354,658 shares. His prior trades at GRNT show a 3-of-5 pattern of well-timed buys at the 90-day mark, suggesting some skill in entry timing at this ticker. However, context is mixed: the stock is down 19.2% from its 52-week high and the company posted -3.6% annual revenue growth despite current profitability (net income $9.8M on $122.9M quarterly revenue). The 30-day momentum is strong at +16.6%, but valuation is stretched with a P/E of 63.33, limiting room for further appreciation without fundamental improvement.

Director Darden Thaddeus buys 9,440 shares of GRNT at $6.13; cluster activity with 3 other insiders in past 14 days

Director Darden Thaddeus purchased 9,440 shares at $6.13 on 2024-12-06, increasing his holdings from 221,156 to 230,596 shares. His prior trades at GRNT show a strong timing pattern: 4 of 5 prior buys were well-timed at the 90-day mark, with returns including +15.1% (30d), +7.6% (90d), +10.8% (30d), and +7.5% (90d). The current transaction occurs in a cluster context—3 other insiders also bought within the past 14 days—suggesting coordinated conviction. However, the company faces material headwinds: annual revenue declined 20.8% year-over-year to $94.1M, and the stock trades at $6.13, down 13.0% from its 52-week high of $7.05 and down 5.8% over the past 30 days. The insider's historical accuracy at this ticker provides a counterweight to deteriorating fundamentals, warranting observation of near-term price action relative to his established buy-timing pattern.

Director Darden Thaddeus buys 7,000 shares of GRNT at $5.90; holds 221.2K shares post-trade amid cluster buying and strong same-ticker timing history.

Darden Thaddeus purchased 7,000 shares at $5.90 on 2024-06-14, expanding his position to 221.2K shares (a 3.3% increase). His prior four trades at GRNT across 2023 and early 2024 all showed positive 90-day outcomes (ranging from +5.1% to +22.0%), establishing a consistent pattern of well-timed buys at this ticker. This current purchase occurs within a cluster—2 other insiders also bought within the past 14 days—suggesting board-level alignment. The stock now trades at $5.91, down 26.2% from its 52-week high of $8.01 and down 8.5% in the past 30 days, providing context for this entry point relative to recent weakness. Against this backdrop of simultaneous insider accumulation and historically effective timing at GRNT, the transaction warrants attention to whether recent price declines are attracting informed purchasing.